WallStreetZenWallStreetZen

NASDAQ: ICU
Seastar Medical Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ICU

Based on 1 analyst offering 12 month price targets for Seastar Medical Holding Corp

Min Forecast
$8.00+155.59%
Avg Forecast
$8.00+155.59%
Max Forecast
$8.00+155.59%

Should I buy or sell ICU stock?

Based on 1 analyst offering ratings for Seastar Medical Holding Corp.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ICU's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ICU as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ICU stock forecasts and price targets.

ICU stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-14

1 of 1

Forecast return on equity

Is ICU forecast to generate an efficient return?

Company
-41.94%
Industry
33.6%
Market
151.64%
ICU's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ICU forecast to generate an efficient return on assets?

Company
-27.24%
Industry
-0.45%
ICU is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ICU earnings per share forecast

What is ICU's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$3.61
Avg 2 year Forecast
-$2.31
Avg 3 year Forecast
-$0.77

ICU revenue forecast

What is ICU's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.9M+31.48%
Avg 2 year Forecast
$2.8M+97.21%
Avg 3 year Forecast
$16.2M+1,025.35%
ICU's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ICU revenue growth forecast

How is ICU forecast to perform vs Biotechnology companies and vs the US market?

Company
115.07%
Industry
46.89%
Market
16.36%
ICU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ICU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ICU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ICU$3.13$8.00+155.59%Strong Buy
BIVI$1.66N/AN/A
PHIO$1.10$14.00+1,172.73%Buy
LNAI$2.61N/AN/A
CMMB$1.58N/AN/A
View Top Biotech Stocks

Seastar Medical Holding Stock Forecast FAQ

Is Seastar Medical Holding Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ICU) stock is to Strong Buy ICU stock.

Out of 1 analyst, 1 (100%) are recommending ICU as a Strong Buy, 0 (0%) are recommending ICU as a Buy, 0 (0%) are recommending ICU as a Hold, 0 (0%) are recommending ICU as a Sell, and 0 (0%) are recommending ICU as a Strong Sell.

If you're new to stock investing, here's how to buy Seastar Medical Holding stock.

What is ICU's earnings growth forecast for 2026-2028?

(NASDAQ: ICU) Seastar Medical Holding's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 69.68%.

Seastar Medical Holding's earnings in 2026 is -$11,899,000.On average, 3 Wall Street analysts forecast ICU's earnings for 2026 to be -$14,411,990, with the lowest ICU earnings forecast at -$14,023,082, and the highest ICU earnings forecast at -$14,940,793. On average, 3 Wall Street analysts forecast ICU's earnings for 2027 to be -$9,224,681, with the lowest ICU earnings forecast at -$9,714,314, and the highest ICU earnings forecast at -$8,771,421.

In 2028, ICU is forecast to generate -$3,068,099 in earnings, with the lowest earnings forecast at -$2,976,967 and the highest earnings forecast at -$3,189,608.

What is ICU's revenue growth forecast for 2026-2028?

(NASDAQ: ICU) Seastar Medical Holding's forecast annual revenue growth rate of 115.07% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 46.89%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.36%.

Seastar Medical Holding's revenue in 2026 is $1,436,000.On average, 3 Wall Street analysts forecast ICU's revenue for 2026 to be $7,546,340, with the lowest ICU revenue forecast at $6,806,894, and the highest ICU revenue forecast at $8,393,704. On average, 3 Wall Street analysts forecast ICU's revenue for 2027 to be $11,319,510, with the lowest ICU revenue forecast at $10,212,340, and the highest ICU revenue forecast at $12,590,556.

In 2028, ICU is forecast to generate $64,591,552 in revenue, with the lowest revenue forecast at $62,672,991 and the highest revenue forecast at $67,149,634.

What is ICU's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ICU) forecast ROA is -27.24%, which is lower than the forecast US Biotechnology industry average of -0.45%.

What is ICU's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ICU price target, the average ICU price target is $8.00, with the highest ICU stock price forecast at $8.00 and the lowest ICU stock price forecast at $8.00.

The Wall Street analyst predicted that Seastar Medical Holding's share price could reach $8.00 by May 14, 2027. The average Seastar Medical Holding stock price prediction forecasts a potential upside of 155.59% from the current ICU share price of $3.13.

What is ICU's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ICU) Seastar Medical Holding's current Earnings Per Share (EPS) is -$3.86. On average, analysts forecast that ICU's EPS will be -$3.61 for 2026, with the lowest EPS forecast at -$3.51, and the highest EPS forecast at -$3.74. On average, analysts forecast that ICU's EPS will be -$2.31 for 2027, with the lowest EPS forecast at -$2.43, and the highest EPS forecast at -$2.19. In 2028, ICU's EPS is forecast to hit -$0.77 (min: -$0.74, max: -$0.80).

What is ICU's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ICU) forecast ROE is -41.94%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.